In this podcast, Gregory Krauss, MD, discusses his research on cenobamate as adjunctive therapy for adults with uncontrolled focal seizures, how the results of this research aided in cenobamate's approval by the US Food and Drug Administration, and more. More at: www.consultant360.com/neurology.
